Incidence of Postoperative Residual Neuromuscular Blockade in the Era of Sugammadex

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

52 participants

Study Classification

OBSERVATIONAL

Study Start Date

2023-03-15

Study Completion Date

2024-08-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study is a prospective observational study. A total 52 patients will be included in this study. We will observe the incidence of postoperative residual neuromuscular blockade in patients receiving sugammadex.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Recovery of Muscle Function After Deep Neuromuscular Block by Means of Diaphragm Ultrasonography

NCT02698969

Post-operative Residual Curarization

UNKNOWN PHASE4

Reversal of Neuromuscular Blockade With Sugammadex or Usual Care in Hip Fracture Surgery or Joint (Hip/Knee) Replacement (P07038)

NCT01422304

Neuromuscular Blockade Arthroplasty, Replacement, Hip Arthroplasty, Replacement, Knee +2 more

COMPLETED PHASE3

Comparative Study of Sugammadex Versus Neostigmine for Reversal of Neuromuscular Blockade in Morbidly Obese Patients

NCT01629394

Morbid Obesity Neuromuscular Blockade

UNKNOWN PHASE2/PHASE3

Effect of Neuromuscular Blockade on Operating Conditions and Overall Satisfaction During Spinal Surgery

NCT02724111

Neuromuscular Blockade Surgery Anesthesia +1 more

COMPLETED PHASE4

Neuromuscular Blockade Improves Surgical Conditions

NCT00895778

Neuromuscular Blockade

COMPLETED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Postoperative Residual Curarization

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Sugammadex

At the end of surgery, neuromucular blockade will be reversed with 2mg/kg or 4mg/kg sugammadex depending on the depth of neuromuscular blockade.

Intervention Type DRUG

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patients undergoing elective surgery under general anesthesia.
* American Society of Anesthesiologists grade 1, 2, or 3.
* Aged \>18 years

Exclusion Criteria

* Refusal to participate in the study
* Body Mass Index \< 18.5 kg/m2 or \> 35 kg/m2
* History of neuromuscular disease.
* History of allergy to neuromuscular blockade
* Scheduled to transfer to the intensive care unit

Minimum Eligible Age

19 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No